Effects of human parvovirus B19 VP1 unique region protein on macrophage responses

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Tzang, Bor Show ^a   Chiu, Chun Ching ^a,b   Tsai, Chun Chou ^a   Lee, Yi Ju ^a   Lu, I Jung ^c   Shi, Jing Yu ^a   Hsu, Tsai Ching ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHIHLEE INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PHOSPHOLIPASE A2; STRESS ACTIVATED PROTEIN KINASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; IMMUNOBLOTTING; MACROPHAGE; MOUSE; NONHUMAN; PARVOVIRUS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL LINE; CELL MOTION; CYTOLOGY; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

PARVOVIRUS;

ANIMALS; CELL LINE; CELL MOVEMENT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; PARVOVIRUS B19, HUMAN; PHAGOCYTOSIS; PHOSPHOLIPASES A; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63449124484     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-13     Document Type: Article

References (39)

1. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. A Corcoran S Doyle, J Med Microbiol 2004 53 459 475 10.1099/jmm.0.05485-0 15150324
2. Parvovirus B19. NS Young KE Brown, N Engl J Med 2004 350 586 597 10.1056/NEJMra030840 14762186
3. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. FB Rayment E Crosdale DJ Morris JR Pattison P Talbot JJ Clare, J Gen Virol 1990 71 2665 2672 10.1099/0022-1317-71- 11-2665 1701479
4. Antibody responses in parvovirus B19 infected patients. S Modrow S Dorsch, Pathol Biol (Paris) 2002 50 326 331 12116851
5. Human parvovirus B19: ELISA and immunoblot assays. TF Schwarz M Roggendorf F Deinhardt, J Virol Methods 1988 20 155 168 10.1016/0166-0934(88) 90149-8 2843558
6. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. GJ Kurtzman BJ Cohen AM Field R Oseas RM Blaese NS Young, J Clin Invest 1989 84 1114 1123 2551923 10.1172/JCI114274
7. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. S Anderson M Momoeda M Kawase S Kajigaya NS Young, Virology 1995 206 626 632 10.1016/S0042-6822(95)80079-4 7530397
8. A viral phospholipase A2 is required for parvovirus infectivity. Z Zádori J Szelei MC Lacoste Y Li S Gariépy P Raymond M Allaire IR Nabi P Tijssen, Dev Cell 2001 1 291 302 10.1016/S1534-5807(01)00031-4 11702787
9. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. S Dorsch G Liebisch B Kaufmann P von Landenberg JH Hoffmann W Drobnik S Modrow, J Virol 2002 76 2014 2018 11799199 10.1128/JVI.76.4.2014- 2018.2002
10. Interfacial enzymology of parvovirus phospholipases A2. S Canaan Z Zádori F Ghomashchi J Bollinger M Sadilek ME Moreau P Tijssen MH Gelb, J Biol Chem 2004 279 14502 14508 10.1074/jbc.M312630200 14726513
11. Activation of Synoviocytes by the Secreted Phospholipase A2 Motif in the VP1-Unique Region of Parvovirus B19 Minor Capsid Protein. J Lu N Zhi S Wong KF Brown, J Infect Dis 2006 193 582 590 10.1086/499599 16425138
12. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. C Filippone N Zhi S Wong J Lu S Kajigaya G Gallinella L Kakkola M Söderlund-Venermo NS Young KE Brown, Virology 2008 374 444 452 10.1016/j.virol.2008.01.002 18252260
13. The phospholipase A2 superfamily and its group numbering system. RH Schaloske EA Dennis, Biochimica et Biophysica Acta 2006 1761 1246 59 16973413
14. The cell biology of macrophage activation. DO Adams TA Hamilton, Annu Rev Immunol 1984 2 283 318 10.1146/annurev.iy.02.040184.001435 6100475
15. Macrophages in inflammation. N Fujiwara K Kobayashi, Curr Drug Targ Inflam Aller 2005 4 281 286 10.2174/1568010054022024
16. Macrophage activation by endogenous danger signals. X Zhang DM Mosser, J Pathol 2008 214 161 178 10.1002/path.2284 18161744
17. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. JR Kerr VS Cunniffe P Kelleher AJ Coats DL Mattey, J Med Virol 2004 74 147 155 10.1002/jmv.20158 15258981
18. Cytokines in autoimmunity. FM Brennan M Feldmann, Curr Opin Immunol 1996 8 872 877 10.1016/S0952-7915(96)80018-5 8994869
19. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. KL MacNaul NI Hutchinson JN Parsons EK Bayne MJ Tocci, J Immunol 1990 145 4154 4166 2258613
20. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. FA Attiga PM Fernandez AT Weeraratna MJ Manyak SR Patierno, Cancer Res 2000 60 4629 4637 10969817
21. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. CJ Yuan AK Mandal Z Zhang AB Mukherjee, Cancer Res 2000 60 1084 1091 10706128
22. Evidence that porcine pancreatic phospholipase A2 via its high affinity receptor stimulates extracellular matrix invasion by normal and cancer cells. GC Kundu AB Mukherjee, J Biol Chem 1997 272 2346 2353 10.1074/jbc.272.47.29468 8999944
23. Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. H Arita K Hanasaki T Nakano S Oka H Teraoka K Matsumoto, J Biol Chem 1991 266 19139 19141 1918029
24. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2- mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. YA Choi HK Lim JR Kim CH Lee YJ Kim SS Kang SH Baek, J Biol Chem 2004 279 36579 36585 10.1074/jbc.M314235200 15220345
25. cAMP elevating agents suppress secretory phospholipase A2-induced matrix metalloproteinase-2 activation. CH Lee J Lee YA Choi SS Kang SH Baek, Biochem Biophys Res Commun 2006 340 1278 1283 10.1016/j.bbrc.2005.12.136 16414357
26. Group IVA phospholipase A2-associated production of MMP-9 in macrophages and formation of atherosclerotic lesions. II Hiromi H Naoya T Issei O Mayuko S Takashi A Satoshi, Biol Pharm Bull 2008 31 363 368 10.1248/bpb.31.363 18310893
27. The association of VP1 unique region protein in acute parvovirus B19 infection and antiphospholipid antibody production. BS Tzang GJ Tsay YJ Lee C Li YS Sun TC Hsu, Clin Chim Acta 2007 378 59 65 10.1016/j.cca.2006.10.016 17169353
28. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human Parvovirus B19 VP1 unique region protein. BS Tzang YJ Lee TP Yang GJ Tsay JY Shi CC Tsai TC Hsu, Clin Chim Acta 2007 382 31 36 10.1016/j.cca.2007.03.014 17451664
29. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein. BS Tzang CC Tsai CC Chiu JY Shi TC Hsu, Clin Chim Acta 2008 395 77 83 10.1016/j.cca.2008.05.012 18538665
30. Evaluation of phagocytic activity in human monocyte-derived dendritic cells. SG Kiama L Cochand L Karlsson LP Nicod P Gehr, Aerosol Med 2001 14 289 299 10.1089/089426801316970240
31. Human parvovirus B19 nonstructural protein (NS1) induces apoptosis through mitochondria cell death pathway in monkey epithelial COS-7 cells. TC Hsu WJ Wu MC Chen GJ Tsay, Scand J Infect Dis 2004 36 570 577 10.1080/ 00365540410016230 15370668
32. Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. PN Chen WH Kuo CL Chiang HL Chiou YS Hsieh SC Chu, Chem Biol Interact 2006 163 218 229 10.1016/j.cbi.2006.08.003 16970933
33. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. H Towbin T Staehelin J Gordon, Proc Natl Acad Sci USA 1979 76 4350 4354 388439 10.1073/pnas.76.9.4350
34. Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. M Menshikov N Torosyan E Elizarova K Plakida A Vorotnikov Y Parfyonova V Stepanova A Bobik B Berk V Tkachuk, Vasc Res 2006 43 482 490 10.1159/000095248
35. PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis. J Oestvang B Johansen, Biochim Biophys Acta 2006 1761 1309 1316 16904370
36. Phospholipase A(2) in vascular disease. E Hurt-Camejo G Camejo H Peilot K Oörni P Kovanen, Circ Res 2001 89 298 304 10.1161/hh1601.095598 11509445
37. Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. P Vikman S Ansar M Henriksson E Stenman L Edvinsson, Exp Brain Res 2007 183 499 510 10.1007/s00221-007-1062-5 17828393
38. Secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. EJ Jo HY Lee YN Lee JI Kim HK Kang DW Park SH Baek JY Kwak YS Bae, J Immunol 2004 173 6433 6439 15528384
39. Matrix Metalloproteinase-9 and autoimmune diseases. M Ram Y Sherer Y Shoenfeld, J Clin Immunol 2006 26 299 307 10.1007/s10875-006-9022-6 16652230